Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Estrogen biosynthesis in adipose tissue increases with age and obesity, and has been implicated in the development of endometrial cancer and breast cancer. In normal human adipose tissue, expression of the CYP19 gene which encodes
aromatase
P450, the enzyme responsible for estrogen biosynthesis, is regulated by a distal promoter, namely promoter I.4. Stimulation of expression in adipose stromal cells by members of the type 1 cytokine family, i.e. interleukin (IL)-6, IL-11, leukemia inhibitory factor (LIF) and oncostatin M (OSM), is mediated via a Jak-STAT3 signaling pathway and a
GAS
element upstream of promoter I.4. In contrast,
aromatase
expression in breast adipose tissue proximal to tumor is increased three- to four-fold to the utilization of another promoter, namely promoter II, proximal to the translation initiation site. In the present report, we show that prostaglandin (PG) E2 is the most potent factor which stimulates
aromatase
expression via cyclic AMP and promoter II. PGE2 acts via EP1 and EP2 receptor subtypes to stimulate both the PKC and PKA pathways. The combined stimulation of both of these pathways results in the maximal expression of promoter II-specific CYP19 transcripts. Because PGE2 is a major secretory product both of breast tumor epithelial cells and fibroblasts, as well as of macrophages infiltrating the tumor site, then this could be the mechanism whereby estrogen biosynthesis is stimulated in breast sites adjacent to a tumor, leading in turn to increased growth and development of the tumor itself.
...
PMID:Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. 936 91
The ability of the testis to convert irreversibly androgens into estrogens is related to the presence of a microsomal enzymatic complex named
aromatase
. Although somatic cells and germ cells (GC) have the capacity to produce estrogens the regulation of the CYP19 gene expression in adult rat testicular cells and specially in freshly purified Leydig cells, pachytene spermatocytes (PS) and round spermatids (RS) is not fully understood. In the present study we have analyzed the putative effects of steroid hormones, transforming growth factor beta (TGFbeta), cytokine (tumor necrosis factor alpha, TNFalpha) and dexamethasone (Dex) on CYP19 expression in these purified testicular cells from adult rat. In parallel the biological role of seminiferous tubules and Sertoli cells conditioned media on the expression of
aromatase
was studied. Using a highly specific quantitative competitive RT-PCR we established that testosterone (T) enhances CYP19 gene expression in Leydig cells and germ cells, and augments the estradiol outputs. The non-aromatizable androgen 5alpha-DHT induces the same effect as T on P450
aromatase
(P450arom) gene expression but was inefficient on the estradiol output. In PS and RS an inhibitory effect on CYP19 gene transcription was observed with TGFbeta (1 ng/ml) alone or in combination with T. Conversely, the addition of TNFalpha (20 ng/ml) increases the P450arom transcription in PS although an inhibitory effect is observed in RS. Together with T, TNFalpha decreases the amount of P450arom mRNA in PS and RS. In PS we found that Dex regulates positively CYP19 expression and negatively in RS. Furthermore in PS a synergistic effect of Dex and TNFalpha on P450arom mRNA expression was observed whereas an additive one was recorded for RS. Therefore in germ cells TNFalpha likely enhances expression of
aromatase
through promoter PI.4 in PS, possibly via an AP1 site upstream the
GAS
element, while in RS TNFalpha requires glucocorticoids as a co-stimulator to increase CYP19 gene expression. Finally in presence of seminiferous tubules or Sertoli cell conditioned media, the amount of
aromatase
transcripts is increased in both Leydig cells and germ cells therefore suggesting that other locally produced modulators, yet unknown, but from Sertoli cell origin, are concerned in the regulation of the
aromatase
gene expression in rat testicular cells. In summary, using an in vitro model of mature rat Leydig cells, pachytene spermatocytes and round spermatids, we have shown that several factors direct the expression of the
aromatase
gene and it is obvious that not only promoter PII but also promoter PI.4 are concerned.
...
PMID:Regulation of aromatase gene expression in Leydig cells and germ cells. 1462 30
Aromatase is the terminal enzyme responsible for estrogen biosynthesis in mammals; it is present in various testicular cells including germ cells. The
aromatase
gene (Cyp19) is unique in humans and its expression is regulated in a tissue and more precisely, in a cell-specific manner via the alternative use of various promoters located in the first exon. Nevertheless, there is little information concerning the regulation of the testicular
aromatase
especially in germ cells. This prompted us to study the control of Cyp19 gene expression and its role in the regulation of the testicular androgen/estrogen ratio. Gonadotrophins and cAMP modulate
aromatase
expression in somatic cells which confirms that promoter II is controlled via CRE. Moreover, we have demonstrated that in highly purified germ cells from adult rats (pachytene spermatocytes and round spermatids), transforming growth factor beta (TGFbeta) inhibited the expression of Cyp19 in both germ cell types. In contrast, tumor necrosis factor alpha (TNFalpha) stimulated Cyp19 expression in pachytene spermatocytes. The effect of TNFalpha is amplified in presence of dexamethasone. Therefore, we suggest that in germ cells, TNFalpha enhances expression of
aromatase
through promoter PI.4 in pachytene spermatocytes, possibly via an AP1 site upstream the
GAS
element, while in round spermatids TNF requires glucocorticoids as a co-stimulator to increase Cyp19 gene expression. In addition, we have shown that androgens and estrogens by themselves modulate Cyp19 gene expression in all testicular cell types studied suggesting the presence of ARE and ERE on the Cyp19 gene promoter(s). Finally, in presence of seminiferous tubules or Sertoli cell-conditioned media,
aromatase
transcripts are increased in both Leydig cells and germ cells suggesting that other locally produced modulators (e.g. LRH-1) are involved in the regulation of the
aromatase
gene expression especially in Leydig cells. Using RACE (Rapid Amplification of cDNA Ends)-PCR, we have confirmed that promoter II mainly directs expression of the
aromatase
gene in all testicular cell types studied in the rat. However, involvement of another promoter such as PI.4 is suggested as well.
...
PMID:The promoter(s) of the aromatase gene in male testicular cells. 1509 93